Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Croda International ( (GB:CRDA) ) has issued an update.
Croda International disclosed that Executive Committee member Sandra Elaine Breene exercised conditional share awards under the company’s Performance Share Plan 2014 and Deferred Bonus Share Plan, both originally granted in March 2023. Following the vesting of 2,307 ordinary shares in total, she sold a portion of the stock on the London Stock Exchange to cover associated tax liabilities, signalling routine executive equity compensation activity rather than a change in strategic direction.
The transactions involved nil-cost exercises of 378 shares under the performance plan and 1,929 shares under the deferred bonus plan, with subsequent sales of 1,090 shares at £26.057 each to satisfy tax obligations. Such dealings, formally notified under market disclosure rules, provide transparency around insider share movements for investors and regulators, but do not indicate any immediate shift in Croda’s operating outlook or capital structure.
The most recent analyst rating on (GB:CRDA) stock is a Buy with a £2917.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.
Spark’s Take on CRDA Stock
According to Spark, TipRanks’ AI Analyst, CRDA is a Neutral.
The score reflects solid financial stability (manageable leverage and positive cash generation) and supportive technical momentum, balanced against a demanding valuation (high P/E) and execution risk highlighted on the earnings call (exceptional charges and segment volatility despite improving guidance and transformation progress).
To see Spark’s full report on CRDA stock, click here.
More about Croda International
Croda International Plc is a specialty chemicals company that develops and manufactures high-performance ingredients and technologies for sectors including personal care, life sciences, and industrial markets. The group focuses on innovation-led, high-margin materials used in consumer products and industrial applications worldwide.
Average Trading Volume: 560,821
Technical Sentiment Signal: Strong Sell
Current Market Cap: £3.7B
For detailed information about CRDA stock, go to TipRanks’ Stock Analysis page.